[go: up one dir, main page]

AU2505599A - Method for the prevention and treatment of a type i hypersensitivity disorder - Google Patents

Method for the prevention and treatment of a type i hypersensitivity disorder

Info

Publication number
AU2505599A
AU2505599A AU25055/99A AU2505599A AU2505599A AU 2505599 A AU2505599 A AU 2505599A AU 25055/99 A AU25055/99 A AU 25055/99A AU 2505599 A AU2505599 A AU 2505599A AU 2505599 A AU2505599 A AU 2505599A
Authority
AU
Australia
Prior art keywords
prevention
treatment
type
hypersensitivity disorder
hypersensitivity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25055/99A
Inventor
Barry Michael Ronald Woloski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cangene Corp
Original Assignee
Cangene Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cangene Corp filed Critical Cangene Corp
Publication of AU2505599A publication Critical patent/AU2505599A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Transplantation (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU25055/99A 1998-02-10 1999-02-09 Method for the prevention and treatment of a type i hypersensitivity disorder Abandoned AU2505599A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US7426998P 1998-02-10 1998-02-10
US60074269 1998-02-10
US9252898P 1998-07-13 1998-07-13
US60092528 1998-07-13
PCT/CA1999/000109 WO1999040939A1 (en) 1998-02-10 1999-02-09 Method for the prevention and treatment of a type i hypersensitivity disorder

Publications (1)

Publication Number Publication Date
AU2505599A true AU2505599A (en) 1999-08-30

Family

ID=26755448

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25055/99A Abandoned AU2505599A (en) 1998-02-10 1999-02-09 Method for the prevention and treatment of a type i hypersensitivity disorder

Country Status (3)

Country Link
AU (1) AU2505599A (en)
CA (1) CA2320104A1 (en)
WO (1) WO1999040939A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030055026A1 (en) 2001-04-17 2003-03-20 Dey L.P. Formoterol/steroid bronchodilating compositions and methods of use thereof
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
MY162179A (en) * 2004-04-01 2017-05-31 Elan Pharm Inc Steroid sparing agents and methods of using same

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2724182B1 (en) * 1994-09-02 1996-12-13 Pasteur Institut OBTAINING A RECOMBINANT MONOCLONAL ANTIBODY FROM A HUMAN ANTI-RHESUS D MONOCLONAL ANTIBODY, ITS PRODUCTION IN INSECT CELLS, AND USES THEREOF

Also Published As

Publication number Publication date
CA2320104A1 (en) 1999-08-19
WO1999040939A1 (en) 1999-08-19

Similar Documents

Publication Publication Date Title
AU9040098A (en) Compounds and method for the prevention and treatment of diabetic retinopathy
AU7538398A (en) Emulsion for well and formation treatment
AU7600198A (en) Formation treatment method using deformable particles
AU1945597A (en) Titanium or titanium alloy member and surface treatment method therefor
HUP0104410A3 (en) A composition for the prevention and/or treatment of atherosclerosis
AU1509999A (en) Herbal drug composition for the prevention and treatment of dementia
AU2469599A (en) Methods for the prevention and treatment of fibrosis and sclerosis
AU2825295A (en) Method for the treatment, prevention or minimization of hair loss
AU1527099A (en) Solid products and methods for the remineralization and prevention of demineralization of teeth
AU5838700A (en) Method for treating and preventing finger disorders
AU6946594A (en) Methods for the treatment and prevention of diarrhea
AU3488699A (en) Surface treatment process and system
AU5298699A (en) Dnazymes and methods for treating hpv-related disorders
AU1019699A (en) A medicine for treating algomenorrhea and the method of preparation thereof
AU3119100A (en) Methods for the prevention and treatment of post-surgical complications
AU2139097A (en) Methods of treating or preventing sleep apnea
AU2393500A (en) Method for preventing and treating the degeneration of neurons
EP0796621A3 (en) Preventing and treating periodontal disease
AU2505599A (en) Method for the prevention and treatment of a type i hypersensitivity disorder
AU3861595A (en) A screw and method for the manufacturing and treatment of a screw
AU2964199A (en) Prevention and treatment of adhesions
AU3731499A (en) Waste treatment bag and method of manufacturing the same
AU6819598A (en) Anti-counterfeit method and product using the method
AU2750297A (en) Methods for prevention and/or treatment of neutropenia
AU4107797A (en) Compounds for the treatment and prevention of diabetes

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase